IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don Cheng who wrote (250)	12/17/1996 6:25:00 PM
From: Brad C. Dunlap	of 1762

Hi Don, your post is very accurate and in reallity SKB's recent sale is of very little consequence when looking at the big picture. SKB sold a chunk of stock last year at this time and with the amount of $ that they have committed in r&d makes this sale look prudent. Why not take some money off the table when the real return on investment will come by SKB selling the drug. The fact that the results from phase I and II have been very positive and SKB reaction has been very consistent, which is to take some $ out of the mkt does not bother me at all. I will admit on the surface and to the public it can be interpreted in a negative slant.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next